Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.48 | -36.51 |
| PEG Ratio (TTM) | 8.94 | -2.30 |
| P/S Ratio (TTM) | 1.49 | 2.31 |
| P/B Ratio (TTM) | 1.13 | 4.22 |
| P/FCF Ratio (TTM) | -61.22 | 108.74 |
| Price to 5YR AVG Earnings Ratio | 15.94 | -28.12 |
| Price to 5YR AVG FCF Ratio | -21.40 | -14.17 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.53% | 407.17% |
| ROE (TTM) | 7.83% | 984.07% |
| Net Profit Margin (TTM) | 10.25% | 14.27% |
| ROIC 5YR AVG | 4.66% | 7.96% |
Growth (58%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 90.97% | 5.95% | 4.79% |
| Revenue | 4.50% | 1.14% | 4.94% |
| Net Income | 92.39% | 7.97% | 7.91% |
| Cash Flow | 41.02% | -8.69% | 36.07% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.75 | 0.95 |
| Quick Ratio (TTM) | 0.48 | 0.85 |
| D/E Ratio (TTM) | 1.03 | 3.87 |
| Interest Coverage (TTM) | 2.11 | 2.46 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 0.84 | 0.81 |
| LTL to 5YR AVG FCF | -19.94 | -0.43 |
| Shares Outstanding Growth 5YR AVG | 3.08% | 2.07% |